Pseudomonas Management
Our new cloud based water management system, Tetras, is helping to control and manage Pseudomonas by providing clients with access to their water sample results through their online dashboard. By using Tetras, estates and facilities managers can be confident their site is compliant or address any issues whilst saving valuable time, money and resources.
Pseudomonas Management With Tetras
Using the latest technology and over 25 years of experience in water sampling, we are revolutionising Pseudomonas management with Tetras, our Cloud Based Water Management System.
Water Sampling
Our City and Guilds accredited samplers will sample your water following the HTM04-01, 2016 recommendations. Your sample results will then be sent to a UKAS approved laboratory for expert analysis in order to highlight any water risks.
Water Management
As we barcode your outlets, all sample results will be automatically uploaded into your online dashboard. Here you can trend results, gain a holistic overview, view potential risks and raise a case. Therefore, your site’s Pseudomonas risk is much easier to manage so you can focus on improving your water quality.
Tetras and Pseudomonas Control
Initially, Tetras will identify any water quality issues, such as Pseudomonas counts. Although Tetras is a no obligation service, our engineers can offer advice on how our Orca copper silver ionisation system can treat your water, if necessary.
Tetras is included when you install an Orca water treatment system. At ProEconomy, we recommend using both Tetras and the Orca to control Pseudomonas and avoid non compliance issues.
For more information on our cloud based water management system, click here or contact our team. You can also read more about Pseudomonas here.
Livermore, D.A., 2002, Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?, Clinical Infectious Diseases, 34, 634-64.
“Pseudomonas aeruginosa carries multiresistance plasmids less often than does Klebsiella pneumoniae, develops mutational resistance to cephalosporins less readily than Enterobacter species, and has less inherent resistance than Stenotrophomonas maltophilia. What nevertheless makes P. aeruginosa uniquely problematic is a combination of the following: the species’ inherent resistance to many drug classes; its ability to acquire resistance, via mutations, to all relevant treatments; its high and increasing rates of resistance locally; and its frequent role in serious infections. A few isolates of P. aeruginosa are resistant to all reliable antibiotics, and this problem seems likely to grow with the emergence of integrins that carry gene cassettes encoding both carbapenemases and amikacin acetyltransferases.”
